These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 6006069)
21. A survey of the drugs with activity against M. leprae in mice. Shepard CC Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080 [No Abstract] [Full Text] [Related]
24. Repository acedapsone in leprosy chemoprophylaxis and treatment. Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC Lancet; 1971 Sep; 2(7723):525-6. PubMed ID: 4105668 [No Abstract] [Full Text] [Related]
25. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy. Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413 [TBL] [Abstract][Full Text] [Related]
26. Drug resistance in Nepali leprosy patients. Butlin CR; Neupane KD; Failbus SS; Morgan A; Britton WJ Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):136-41. PubMed ID: 8690972 [TBL] [Abstract][Full Text] [Related]
27. The clinical diagnosis of dapsone resistant leprosy. Taylor PM Lepr India; 1982 Jan; 54(1):117-22. PubMed ID: 7047897 [TBL] [Abstract][Full Text] [Related]
28. A new method for the manufacture of bis(4-aminophenyl)-sulfone and the anti-leprosy, anti-tuberculosis, and antibiotic activities of some new derivatives related to the drug. I. Sah PP; Peoples SA; Kwan ST; Sah HJ Arzneimittelforschung; 1967 Apr; 17(4):425-51. PubMed ID: 5632435 [No Abstract] [Full Text] [Related]
29. Dapsone drug resistance in the MDT era. Roche PW; Neupane KD; Failbus SS; Butlin CR Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097 [No Abstract] [Full Text] [Related]
32. Intramuscular injection of dapsone in therapy for leprosy: a new approach. Modderman ES; Huikeshoven H; Zuidema J; Leiker DL; Merkus FW Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):51-6. PubMed ID: 7061179 [TBL] [Abstract][Full Text] [Related]
33. Clinical stages in sulfone treatment of leprosy. Rodriguez JN Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411 [No Abstract] [Full Text] [Related]
34. [Activity of a monosubstituted sulfone: succinyl-diaminodiphenyl-sulfone in leprosy]. FLOCH H; DESTOMBES P Int J Lepr; 1951; 19(2):147-51. PubMed ID: 14873381 [No Abstract] [Full Text] [Related]
35. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy. Hastings RC; Trautman JR; Mansfield RE Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014 [No Abstract] [Full Text] [Related]
36. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505 [TBL] [Abstract][Full Text] [Related]
37. Some thoughts on the present status and future prospects of chemotherapy of leprosy based on experience with treating tuberculosis. Acocella G Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):331-40. PubMed ID: 7198623 [No Abstract] [Full Text] [Related]
38. Gas chromatographic methods for analysis of sulfone drugs used in leprosy chemotherapy. Burchfield HP; Storrs EE; Wheeler RJ; Bhat VK; Green LL Anal Chem; 1973 May; 45(6):916-20. PubMed ID: 4762374 [No Abstract] [Full Text] [Related]
39. Six cases of dapsone-resistant tuberculoid leprosy. Pearson JM; Kiran KU; Stanley JN Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):534-5. PubMed ID: 6399070 [No Abstract] [Full Text] [Related]
40. [Histoid leprosy: clinical and experimental observations (author's transl)]. Li WZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Mar; 3(1):23-6. PubMed ID: 6458388 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]